XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Registered Direct Offering of Common Stock and Pre-funded Warrants [Member]
Common Stock [Member]
Common Stock [Member]
Registered Direct Offering of Common Stock and Pre-funded Warrants [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Registered Direct Offering of Common Stock and Pre-funded Warrants [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Beginning balances at Dec. 31, 2021 $ 144,498   $ 116   $ 444,898   $ (300,521) $ 5
Beginning balance, shares at Dec. 31, 2021     114,036,892          
Issuance of common stock for settlement of RSUs, shares     3,688          
Repurchase of shares for minimum tax withholdings (1)       (1)      
Repurchase of shares for minimum tax withholdings, shares     (720)          
Stock-based compensation 574       574      
Foreign exchange translation adjustment (208)             (208)
Unrealized gain (loss) on short-term investments (88)             (88)
Net loss (8,300)           (8,300)  
Ending balances at Mar. 31, 2022 136,475   $ 116   445,471   (308,821) (291)
Ending balance, shares at Mar. 31, 2022     114,039,860          
Beginning balances at Dec. 31, 2021 144,498   $ 116   444,898   (300,521) 5
Beginning balance, shares at Dec. 31, 2021     114,036,892          
Foreign exchange translation adjustment (1,621)              
Unrealized gain (loss) on short-term investments 9              
Net loss (27,850)              
Ending balances at Sep. 30, 2022 116,514   $ 116   446,376   (328,371) (1,607)
Ending balance, shares at Sep. 30, 2022     114,042,642          
Beginning balances at Mar. 31, 2022 136,475   $ 116   445,471   (308,821) (291)
Beginning balance, shares at Mar. 31, 2022     114,039,860          
Issuance of common stock for settlement of RSUs, shares     1,812          
Repurchase of shares for minimum tax withholdings, shares     (401)          
Stock-based compensation 456       456      
Foreign exchange translation adjustment (745)             (745)
Unrealized gain (loss) on short-term investments 20             20
Net loss (9,164)           (9,164)  
Ending balances at Jun. 30, 2022 127,042   $ 116   445,927   (317,985) (1,016)
Ending balance, shares at Jun. 30, 2022     114,041,271          
Issuance of common stock for settlement of RSUs, shares     1,813          
Repurchase of shares for minimum tax withholdings (1)       (1)      
Repurchase of shares for minimum tax withholdings, shares     (442)          
Stock-based compensation 450       450      
Foreign exchange translation adjustment (668)             (668)
Unrealized gain (loss) on short-term investments 77             77
Net loss (10,386)           (10,386)  
Ending balances at Sep. 30, 2022 116,514   $ 116   446,376   (328,371) (1,607)
Ending balance, shares at Sep. 30, 2022     114,042,642          
Beginning balances at Dec. 31, 2022 $ 107,778   $ 116   446,938   (338,671) (605)
Beginning balance, shares at Dec. 31, 2022 114,046,345   114,046,345          
Issuance of common stock upon exercise of stock options $ 27       27      
Issuance of common stock upon exercise of stock options, shares     17,129          
Issuance of common stock for settlement of RSUs, shares     1,813          
Repurchase of shares for minimum tax withholdings (1)       (1)      
Repurchase of shares for minimum tax withholdings, shares     (551)          
Stock-based compensation 864       864      
Foreign exchange translation adjustment 130             130
Unrealized gain (loss) on short-term investments 14             14
Net loss (10,557)           (10,557)  
Ending balances at Mar. 31, 2023 98,255   $ 116   447,828   (349,228) (461)
Ending balance, shares at Mar. 31, 2023     114,064,736          
Beginning balances at Dec. 31, 2022 $ 107,778   $ 116   446,938   (338,671) (605)
Beginning balance, shares at Dec. 31, 2022 114,046,345   114,046,345          
Issuance of common stock upon exercise of stock options, shares 171,067              
Issuance of common stock for settlement of RSUs, shares 179,419              
Foreign exchange translation adjustment $ (286)              
Unrealized gain (loss) on short-term investments (51)              
Net loss (38,599)              
Ending balances at Sep. 30, 2023 $ 146,544   $ 137   524,619   (377,270) (942)
Ending balance, shares at Sep. 30, 2023 135,339,836   135,339,836          
Beginning balances at Mar. 31, 2023 $ 98,255   $ 116   447,828   (349,228) (461)
Beginning balance, shares at Mar. 31, 2023     114,064,736          
Issuance of common stock upon exercise of stock options 103       103      
Issuance of common stock upon exercise of stock options, shares     84,375          
Issuance of common stock for settlement of RSUs, shares     1,812          
Repurchase of shares for minimum tax withholdings, shares     (468)          
Stock-based compensation 958       958      
Foreign exchange translation adjustment (98)             (98)
Unrealized gain (loss) on short-term investments (60)             (60)
Net loss (11,443)           (11,443)  
Ending balances at Jun. 30, 2023 87,715   $ 116   448,889   (360,671) (619)
Ending balance, shares at Jun. 30, 2023     114,150,455          
Issuance of common stock upon exercise of stock options 64       64      
Issuance of common stock upon exercise of stock options, shares     63,610          
Issuance of common stock and pre-funded warrants in registered direct offering, net of offering costs [1]   $ 74,874   $ 21   $ 74,853    
Issuance of common stock and pre-funded warrants in registered direct offering, net of offering costs, shares [1]       21,000,000        
Issuance of common stock for settlement of RSUs, shares     176,813          
Repurchase of shares for minimum tax withholdings (182)       (182)      
Repurchase of shares for minimum tax withholdings, shares     (51,042)          
Stock-based compensation 995       995      
Foreign exchange translation adjustment (318)             (318)
Unrealized gain (loss) on short-term investments (5)             (5)
Net loss (16,599)           (16,599)  
Ending balances at Sep. 30, 2023 $ 146,544   $ 137   $ 524,619   $ (377,270) $ (942)
Ending balance, shares at Sep. 30, 2023 135,339,836   135,339,836          
[1] As discussed in Note 8. Stockholders’ Equity, the Company sold (i) an aggregate of 21,000,000 shares of the Company’s common stock, par value $0.001 per share and (ii) pre-funded warrants to purchase an aggregate of 5,666,667 shares of the Company's common stock at an exercise price, equal to the par value, of $0.001 per share.